Literature DB >> 18342534

Hypericin phototoxicity induces different modes of cell death in melanoma and human skin cells.

Lester M Davids1, Britta Kleemann, Denisa Kacerovská, Karl Pizinger, Susan H Kidson.   

Abstract

Hypericin, the major component of St. John's Wort, absorbs light in the UV and visible ranges whereupon it becomes phototoxic through the production of reactive oxygen species. Although photodynamic mechanisms (i.e. through endogenous photosensitizers) play a role in UVA phototherapy for the treatment of skin disorders such as eczema and psoriasis, photodynamic therapy employing exogenous photosensitizers are currently being used only for the treatment of certain forms of non-melanoma skin cancers and actinic keratoses. There are few reports however on its use in treating melanomas. This in vitro study analyses the phototoxic effect of UVA (400-315 nm) - activated hypericin in human pigmented and unpigmented melanomas and immortalised keratinocytes and melanocytes. We show that neither hypericin exposure nor UV irradiation alone reduces cell viability. We show that an exposure to 1 microM UVA-activated hypericin does not bring about cell death, while 3 microM activated hypericin induces a necrotic mode of cell death in pigmented melanoma cells and melanocytes and an apoptotic mode of cell death in non-pigmented melanoma cells and keratinocytes. We hypothesis that the necrotic mode of cell death in the pigmented cells is possibly related to the presence of melanin-containing melanosomes in these cells and that the hypericin-induced increase in reactive oxygen species leads to an increase in permeability of melanosomes. This would result in toxic melanin precursors (of an indolic and phenolic nature) leaking into the cytoplasm which in turn leads to cell death. Hypericin localisation in the endoplasmic reticulum in these cells shown by fluorescent microscopy, further support a disruption in cellular processing and induction of cell death. In contrast, this study shows that cells that do not contain melanosomes (non-pigmented melanoma cells and keratinocytes) die by apoptosis. Further, using a mitochondrial-specific fluorescent dye, we show that intracellular accumulation of hypericin induces a mitochondrial-associated caspase-dependent apoptotic mode of cell death. This work suggests that UVA is effective in activating hypericin and that this phototoxicity may be considered as treatment option in some cases of lentigo maligna or lentigo maligna melanoma that are too large for surgical resection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342534     DOI: 10.1016/j.jphotobiol.2008.01.011

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  26 in total

Review 1.  Current position of TNF-α in melanomagenesis.

Authors:  Iuliana Nenu; Diana Tudor; Adriana Gabriela Filip; Ioana Baldea
Journal:  Tumour Biol       Date:  2015-08-18

2.  Solvatochromic and fluorescence behavior of sulfisoxazole.

Authors:  Abdulilah Dawoud Bani-Yaseen
Journal:  J Fluoresc       Date:  2010-12-24       Impact factor: 2.217

3.  Development of a multifunctional luciferase reporters system for assessing endoplasmic reticulum-targeting photosensitive compounds.

Authors:  Shengchao Lin; Lingling Zhang; Kecheng Lei; Anle Zhang; Ping Liu; Jianwen Liu
Journal:  Cell Stress Chaperones       Date:  2014-07-02       Impact factor: 3.667

4.  Growth inhibition of malignant glioblastoma by DING protein.

Authors:  Markus J Bookland; Nune Darbinian; Michael Weaver; Shohreh Amini; Kamel Khalili
Journal:  J Neurooncol       Date:  2011-11-04       Impact factor: 4.130

5.  Time course of apoptosis induced by photodynamic therapy with PsD007 in LT12 acute myeloid leukemia cells.

Authors:  Huijuan Yin; Xuying Ye; Qing Niu; Chao Wang; Yingxin Li
Journal:  Lasers Med Sci       Date:  2016-02-09       Impact factor: 3.161

6.  Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies.

Authors:  Andrés Montoya; Alejandro Daza; Diana Muñoz; Karina Ríos; Viviana Taylor; David Cedeño; Iván D Vélez; Fernando Echeverri; Sara M Robledo
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

Review 7.  Hypericins as potential leads for new therapeutics.

Authors:  Anastasia Karioti; Anna Rita Bilia
Journal:  Int J Mol Sci       Date:  2010-02-04       Impact factor: 5.923

Review 8.  Melanoma resistance to photodynamic therapy: new insights.

Authors:  Ying-Ying Huang; Daniela Vecchio; Pinar Avci; Rui Yin; Maria Garcia-Diaz; Michael R Hamblin
Journal:  Biol Chem       Date:  2013-02       Impact factor: 3.915

9.  Photo-induced processes in collagen-hypericin system revealed by fluorescence spectroscopy and multiphoton microscopy.

Authors:  V Hovhannisyan; H W Guo; A Hovhannisyan; V Ghukasyan; T Buryakina; Y F Chen; C Y Dong
Journal:  Biomed Opt Express       Date:  2014-04-02       Impact factor: 3.732

10.  Differential diagnosis of gallstones by using hypericin as a fluorescent optical imaging agent.

Authors:  Marlein Miranda Cona; Ye-Wei Liu; Antoine Hubert; Ting Yin; Yuan-Bo Feng; Peter de Witte; Etienne Waelkens; Yan-Sheng Jiang; Jian Zhang; Stefaan Mulier; Qian Xia; Gang Huang; Raymond Oyen; Yi-Cheng Ni
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.